Aarti Pharmalabs Limited (NSE: AARTIPHARM)
India flag India · Delayed Price · Currency is INR
696.10
+5.30 (0.77%)
Sep 6, 2024, 3:30 PM IST

Aarti Pharmalabs Statistics

Total Valuation

Aarti Pharmalabs has a market cap or net worth of INR 63.07 billion. The enterprise value is 64.98 billion.

Market Cap 63.07B
Enterprise Value 64.98B

Important Dates

The next estimated earnings date is Thursday, November 7, 2024.

Earnings Date Nov 7, 2024
Ex-Dividend Date Jul 31, 2024

Share Statistics

Aarti Pharmalabs has 90.61 million shares outstanding. The number of shares has increased by 0.04% in one year.

Shares Outstanding 90.61M
Shares Change (YoY) +0.04%
Shares Change (QoQ) -0.02%
Owned by Insiders (%) 29.26%
Owned by Institutions (%) 20.13%
Float 45.15M

Valuation Ratios

The trailing PE ratio is 28.01.

PE Ratio 28.01
Forward PE n/a
PS Ratio 3.24
PB Ratio 3.59
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 28.85
EV / Sales 3.33
EV / EBITDA 16.35
EV / EBIT 20.22
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 16.23
Debt / EBITDA 0.72
Debt / FCF n/a
Interest Coverage 17.98

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) 10.48%
Revenue Per Employee 9.31M
Profits Per Employee 1.08M
Employee Count 2,095
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +58.89% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +58.89%
50-Day Moving Average 624.89
200-Day Moving Average 538.99
Relative Strength Index (RSI) 65.65
Average Volume (20 Days) 372,089

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Aarti Pharmalabs had revenue of INR 19.50 billion and earned 2.25 billion in profits. Earnings per share was 24.85.

Revenue 19.50B
Gross Profit 8.22B
Operating Income 3.21B
Pretax Income 3.10B
Net Income 2.25B
EBITDA 3.97B
EBIT 3.21B
Earnings Per Share (EPS) 24.85
Full Income Statement

Balance Sheet

The company has 943.17 million in cash and 2.85 billion in debt, giving a net cash position of -1.91 billion or -21.07 per share.

Cash & Cash Equivalents 943.17M
Total Debt 2.85B
Net Cash -1.91B
Net Cash Per Share -21.07
Equity (Book Value) 17.57B
Book Value Per Share 193.88
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 42.14%, with operating and profit margins of 16.49% and 11.55%.

Gross Margin 42.14%
Operating Margin 16.49%
Pretax Margin 15.91%
Profit Margin 11.55%
EBITDA Margin 20.38%
EBIT Margin 16.49%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.29%.

Dividend Per Share 2.00
Dividend Yield 0.29%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -0.04%
Shareholder Yield 0.25%
Earnings Yield 3.57%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a